Recently, the project "Key Technology R&D for Universal Gene Delivery Systems," submitted by Shenzhen Cell Valley Biopharmaceutical Group Co., Ltd., was officially approved for funding under the 2025 Shenzhen Key Industry R&D Program.

This project marks another major project approval for Cell Valley, following its approvals as a Shenzhen Major Industrial Public Service Platform, a Shenzhen Peacock Team, and a Shenzhen Achievement Translation Base. It is a full affirmation of Cell Valley's R&D strength in gene delivery, viral vectors, and the underlying technologies of cell and gene therapy. Cell Valley will take this opportunity to accelerate key technology breakthroughs and achievement translation, contributing "Cell Valley strength" to the high-quality development of Shenzhen's biopharmaceutical industry!